Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma
- 31 March 1999
- journal article
- clinical trial
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 82 (3) , 273-280
- https://doi.org/10.1016/s1081-1206(10)62608-7
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Comparative Efficacy and Safety of Twice Daily Fluticasone Propionate Powder Versus Placebo in the Treatment of Moderate AsthmaAnnals of Allergy, Asthma & Immunology, 1997
- A 12-Week Dose-Ranging Study of Fluticasone Propionate Powder in the Treatment of AsthmaJournal of Asthma, 1996
- Fluticasone propionate reduces oral prednisone use while it improves asthma control and quality of life.American Journal of Respiratory and Critical Care Medicine, 1995
- The DiskusTM: A New Multi-Dose Powder Device – Efficacy and Comparison with TurbuhalerTMJournal of Aerosol Medicine, 1995
- Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthmaJournal of Allergy and Clinical Immunology, 1994
- Evaluation of fluticasone propionate (500 μg day−1) administered either as dry powder via a Diskhaler® inhaler or pressurized inhaler and compared with beclomethasone dipropionate (1000 μg day−1) administered by pressurized inhalerRespiratory Medicine, 1993
- Inhaled corticosteroids: benefits and risks.Thorax, 1992
- Integrated plasma cortisol concentration in children with asthma receiving long‐term inhaled corticosteroidsPediatric Pulmonology, 1992
- Diurnal cortisol secretion during therapy with inhaled beclomethasone dipropionate in children with asthmaThe Journal of Pediatrics, 1991
- The human pharmacology of fluticasone propionateRespiratory Medicine, 1990